Concurrently, obesity increases intratumoral CXCL1 concentrations, promoting CXCR2-mediated accumulation of FasL+ G-MDSCs, resulting in heightened Fas/FasL-mediated CD8 TIL apoptosis and immunotherapy resistance (Figure 7). This evidence concerns the gene CXCR2 and obesity disorder.